The initial, ‘accidental’ discovery of this JAK inhibitor’s potential for promoting hair regrowth came about when Yale University was investigating Tofacitinib as a treatment for plaque psoriasis. The patient they were treating also happened to have Alopecia Universalis and had not grown any hair in seven years, yet at the end of the seven month trial, his hair had fully regrown. JAK inhibitor treatment specifically targets the enzymes inside hair follicles which are responsible for maintaining their dormant (telogen) state in cases of Alopecia Areata. In doing so, they stimulate the follicles out of the telogen phase and back into active growth.
This product must be recommended by one of the doctors at Medical Hair Restoration.